Cargando…

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

Detalles Bibliográficos
Autores principales:	Sinha, Sutapa, Secreto, Charla R., Boysen, Justin C., Lesnick, Connie, Wang, Zhiquan, Ding, Wei, Call, Timothy G., Kenderian, Saad J., Parikh, Sameer A., Warner, Steven L., Bearss, David J., Ghosh, Asish K., Kay, Neil E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893033/ https://www.ncbi.nlm.nih.gov/pubmed/33602892 http://dx.doi.org/10.1038/s41408-021-00426-2

Ejemplares similares

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
por: Sinha, Sutapa, et al.
Publicado: (2018)

SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis
por: Maiti, Guru P., et al.
Publicado: (2021)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells
por: Wang, Zhiquan, et al.
Publicado: (2022)

Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
por: Hong, Jun, et al.
Publicado: (2018)

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
por: Parikh, Sameer A., et al.
Publicado: (2021)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

Hhip regulates tumor-stroma-mediated upregulation of tumor angiogenesis
por: Agrawal, Vijayendra, et al.
Publicado: (2017)

Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression
por: Wang, Zhen, et al.
Publicado: (2022)

Dynamics of Microvesicle Generation in B Cell Chronic Lymphocytic Leukemia: Implication in Disease Progression
por: Boysen, Justin, et al.
Publicado: (2016)

Tumour–stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness
por: Le, N H, et al.
Publicado: (2008)

Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021)

Glycoxidised LDL Induced the Upregulation of Axl Receptor Tyrosine Kinase and Its Ligand in Mouse Mesangial Cells
por: Kim, Young Sook, et al.
Publicado: (2012)

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

Immune Evasion Mechanism and AXL
por: Son, Hye-Youn, et al.
Publicado: (2021)

Patent Spring Washer Axles
Publicado: (1878)

Topology Optimization and Multiobjective Optimization for Drive Axle Housing of a Rear Axle Drive Truck
por: Zheng, Bin, et al.
Publicado: (2022)

Hypercapnia alters stroma-derived Wnt production to limit β-catenin signaling and proliferation in AT2 cells
por: Dada, Laura A., et al.
Publicado: (2023)

RED CELL STROMA IN DOGS : STROMA PROTEIN AND STROMA LIPIDES VARY IN DIFFERENT TYPES OF ANEMIA
por: Robscheit-Robbins, F. S., et al.
Publicado: (1955)

Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis
por: Martínez-Nieto, Guillermo A., et al.
Publicado: (2022)

AXL is an oncotarget in human colorectal cancer
por: Martinelli, Erika, et al.
Publicado: (2015)

Analysis of the Vehicle Chassis Axle Fractures
por: Decker, Živilė, et al.
Publicado: (2023)

Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling
por: Wang, Cun, et al.
Publicado: (2016)

Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
por: Oien, Derek B., et al.
Publicado: (2018)

Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS‐mutated ovarian cancer cells with high AXL expression
por: Umemura, Shiori, et al.
Publicado: (2020)

CRISPR Taking the Front Seat in Immunotherapy
por: Kenderian, Saad S., et al.
Publicado: (2020)

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
por: Siegler, Elizabeth L., et al.
Publicado: (2020)

Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway
por: Sun, Qi, et al.
Publicado: (2022)

Axl as a mediator of cellular growth and survival
por: Axelrod, Haley, et al.
Publicado: (2014)

Gas6/Axl in arginine-starvation therapy
por: Tsai, Wen-Bin, et al.
Publicado: (2015)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

A Versatile Axle for the Construction of Disassemblage Rotaxanes
por: Powers, Lucas A., et al.
Publicado: (2016)

Axl signaling is an important mediator of tumor angiogenesis
por: Tanaka, Mai, et al.
Publicado: (2019)

AXL as a Target in Breast Cancer Therapy
por: Colavito, Sierra A.
Publicado: (2020)

Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer
por: Holdman, Xue B., et al.
Publicado: (2015)

AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines
por: Zwernik, Samuel D., et al.
Publicado: (2021)

Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL
por: Dumas, Pierre-Yves, et al.
Publicado: (2019)

RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study
por: Nicolè, Lorenzo, et al.
Publicado: (2021)

Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis
por: Sun, Li-Wei, et al.
Publicado: (2021)

Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth
por: Zhu, Yi-Ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p8d6gun5sq65c2ptk4kiuu5bkk